These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34929377)

  • 1. Prodrugs as new therapies against Chagas disease: in vivo synergy between Trypanosoma cruzi proline racemase inhibitors and benznidazole.
    de Melo GD; Coatnoan N; Gouault N; Cupif JF; Renault J; Cosson A; Uriac P; Blondel A; Minoprio P
    J Glob Antimicrob Resist; 2022 Mar; 28():84-89. PubMed ID: 34929377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.
    Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C
    BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined approaches for drug design points the way to novel proline racemase inhibitor candidates to fight Chagas' disease.
    Berneman A; Montout L; Goyard S; Chamond N; Cosson A; d'Archivio S; Gouault N; Uriac P; Blondel A; Minoprio P
    PLoS One; 2013; 8(4):e60955. PubMed ID: 23613764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection.
    Coutinho L; Ferreira MA; Cosson A; Batista MM; Batista Dda G; Minoprio P; Degrave WM; Berneman A; Soeiro Mde N
    Mem Inst Oswaldo Cruz; 2009 Dec; 104(8):1055-62. PubMed ID: 20140365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen.
    Bryan MA; Norris KA
    Infect Immun; 2010 Feb; 78(2):810-22. PubMed ID: 19917711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
    Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
    Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
    Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
    Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proline racemases are conserved mitogens: characterization of a Trypanosoma vivax proline racemase.
    Chamond N; Cosson A; Coatnoan N; Minoprio P
    Mol Biochem Parasitol; 2009 Jun; 165(2):170-9. PubMed ID: 19428664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.
    Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV
    PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
    Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S;
    J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
    Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of proline racemases from the human protozoan parasite Trypanosoma cruzi and definition of putative protein signatures.
    Chamond N; Grégoire C; Coatnoan N; Rougeot C; Freitas-Junior LH; da Silveira JF; Degrave WM; Minoprio P
    J Biol Chem; 2003 May; 278(18):15484-94. PubMed ID: 12735293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Aspects of the Coadministration of Sterol 14α-Demethylase Inhibitor VFV and Benznidazole in Experimental Mouse Models of Chagas Disease Caused by the Drug-Resistant Strain of Trypanosoma cruzi.
    Guedes-da-Silva FH; Batista DDGJ; Da Silva CF; Pavão BP; Batista MM; Moreira OC; Souza LRQ; Britto C; Rachakonda G; Villalta F; Lepesheva GI; Soeiro MNC
    ACS Infect Dis; 2019 Mar; 5(3):365-371. PubMed ID: 30625275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proline racemases: insights into Trypanosoma cruzi peptides containing D-proline.
    Coatnoan N; Berneman A; Chamond N; Minoprio P
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():295-300. PubMed ID: 19753488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
    da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
    Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designed mono- and di-covalent inhibitors trap modeled functional motions for Trypanosoma cruzi proline racemase in crystallography.
    Amaral PA; Autheman D; de Melo GD; Gouault N; Cupif JF; Goyard S; Dutra P; Coatnoan N; Cosson A; Monet D; Saul F; Haouz A; Uriac P; Blondel A; Minoprio P
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006853. PubMed ID: 30372428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.